- Forums
- ASX - By Stock
- RCE
- Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial
Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial, page-48
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
52.5¢ |
Change
0.005(0.96%) |
Mkt cap ! $122.7M |
Open | High | Low | Value | Volume |
54.0¢ | 54.0¢ | 52.0¢ | $31.76K | 59.32K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1308 | 52.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
53.0¢ | 9975 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1308 | 0.525 |
1 | 9721 | 0.520 |
3 | 45552 | 0.510 |
1 | 50000 | 0.505 |
4 | 186812 | 0.500 |
Price($) | Vol. | No. |
---|---|---|
0.530 | 9975 | 2 |
0.535 | 10341 | 1 |
0.540 | 16851 | 3 |
0.545 | 12278 | 2 |
0.550 | 180601 | 5 |
Last trade - 15.20pm 25/09/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
BPH
BPH ENERGY LTD
David Breeze, Managing Director and Executive Chairman
David Breeze
Managing Director and Executive Chairman
SPONSORED BY The Market Online